Glucose metabolism and pancreatic defects in spinal muscular atrophy.
Glucose metabolism and pancreatic defects in spinal muscular atrophy.
复制标题
DOI:
10.1002/ana.23582
复制
发表时间:
2012-08
影响因子:
11.2
通讯作者:
Kothary, Rashmi
中科院分区:
文献类型:
--
作者:
Bowerman, Melissa;Swoboda, Kathryn J.;Michalski, John-Paul;Wang, Gen-Sheng;Reeks, Courtney;Beauvais, Ariane;Murphy, Kelley;Woulfe, John;Screaton, Robert A.;Scott, Fraser W.;Kothary, Rashmi
Spinal muscular atrophy (SMA) is the number 1 genetic killer of young children. It is caused by mutation or deletion of the survival motor neuron 1 (SMN1) gene. Although SMA is primarily a motor neuron disease, metabolism abnormalities such as metabolic acidosis, abnormal fatty acid metabolism, hyperlipidemia, and hyperglycemia have been reported in SMA patients. We thus initiated an in-depth analysis of glucose metabolism in SMA. Glucose metabolism and pancreas development were investigated in the Smn2B/− intermediate SMA mouse model and type I SMA patients. Here, we demonstrate in an SMA mouse model a dramatic cell fate imbalance within pancreatic islets, with a predominance of glucagon-producing α cells at the expense of insulin-producing β cells. These SMA mice display fasting hyperglycemia, hyperglucagonemia, and glucose resistance. We demonstrate similar abnormalities in pancreatic islets from deceased children with the severe infantile form of SMA in association with supportive evidence of glucose intolerance in at least a subset of such children. Our results indicate that defects in glucose metabolism may play an important contributory role in SMA pathogenesis.
登录
查看更多内容
影响因子:
64.5
作者:
LEFEBVRE, S;BURGLEN, L;MELKI, J
通讯作者:
MELKI, J
影响因子:
2.2
作者:
Kim A;Miller K;Jo J;Kilimnik G;Wojcik P;Hara M
通讯作者:
Hara M
影响因子:
3.7
作者:
Liu Z;Kim W;Chen Z;Shin YK;Carlson OD;Fiori JL;Xin L;Napora JK;Short R;Odetunde JO;Lao Q;Egan JM
通讯作者:
Egan JM
影响因子:
--
作者:
DAHL, DS;PETERS, HA
通讯作者:
PETERS, HA
影响因子:
30.8
作者:
Lefebvre, S;Burlet, P;Melki, J
通讯作者:
Melki, J